首页|期刊导航|生物技术进展|阻塞性睡眠呼吸暂停与肠道菌群相互作用的研究进展

阻塞性睡眠呼吸暂停与肠道菌群相互作用的研究进展OA

Research Progress on Reciprocal Interactions Between Obstructive Sleep Apnea and Gut Microbiota

中文摘要英文摘要

阻塞性睡眠呼吸暂停(obstructive sleep apnea,OSA)是一种常见的慢性睡眠呼吸障碍疾病,以睡眠期间上气道反复塌陷所致间歇性缺氧和睡眠片段化为主要特征.研究表明,肠道菌群的紊乱是OSA诱发多系统病理损害及合并症发展的重要中介机制.综述了OSA背景下肠道菌群的变化,包括α/β多样性异常、厌氧菌富集和短链脂肪酸产生菌减少,以及胆汁酸、氨基酸和脂肪酸等代谢谱系的改变;探讨了菌群及其代谢物在OSA相关高血压和动脉粥样硬化等合并症中的关键驱动作用;整合了以肠道微生态为靶点的干预策略的研究进展,旨在为OSA的机制研究与临床防治提供新的视角和依据.

Obstructive sleep apnea(OSA)is a common chronic sleep-related breathing disorder,characterized primarily by in-termittent hypoxia and sleep fragmentation resulting from the recurrent collapse of the upper airway during sleep.Studies indicat-ed that disturbances of the gut microbiota represent a crucial intermediary mechanism in the multi-system pathological damage and development of comorbidities induced by OSA.Changes in the gut microbiota under OSA conditions,including abnormalities in α/β diversity,enrichment of anaerobic bacteria,reduction in short-chain fatty acid-producing bacteria,as well as alterations in metabolic profiles such as bile acids,amino acids,and fatty acids,were systematically elucidated.Furthermore,the key driv-ing role of gut microbiota and their metabolites in OSA-related comorbidities,such as hypertension and atherosclerosis,was ex-tensively investigated.Concurrently,research progress on intervention strategies targeting the gut microbiome was comprehen-sively integrated.These findings provide new perspectives and a foundation for mechanistic research and clinical management of OSA.

祁晶;吕秀云

内蒙古医科大学附属医院呼吸及危重症医学科,呼和浩特 010110内蒙古医科大学附属医院呼吸及危重症医学科,呼和浩特 010110

生物科学

阻塞性睡眠呼吸暂停肠道菌群代谢物高血压动脉粥样硬化

obstructive sleep apneagut microbiotametaboliteshypertensionatherosclerosis

《生物技术进展》 2026 (2)

338-347,10

内蒙古自治区自然科学基金联合项目(2025LHMS08072).

10.19586/j.2095-2341.2025.0162

评论